Rosuvastatin, a commonly prescribed lipid-lowering medication for primary and secondary prevention of cardiovascular disease, is generally considered safe with associated mortality benefits. Despite its overall safety profile, the drug is not without side effects. Statin-induced myopathy, a known complication, can manifest in 10-25% of cases, while more uncommon complications such as rhabdomyolysis occur in less than 0.1% of treated patients. In this case report, we present an 80-year-old female presenting with rhabdomyolysis attributable to rosuvastatin.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
case report
8
80-year-old female
8
report rosuvastatin
4
rosuvastatin induced
4
induced rhabdomyolysis
4
rhabdomyolysis 80-year-old
4
female rosuvastatin
4
rosuvastatin commonly
4
commonly prescribed
4
prescribed lipid-lowering
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!